News News Analysis Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2612 (Published 29 June 2020) Cite this as: BMJ 2020;369:m2612 Read our latest coverage of the coronavirus pandemic Article Related content Metrics Responses Peer review Related articles News Covid-19: Where are we on immunity and vaccines? Published: 05 August 2020; BMJ 370 doi:10.1136/bmj.m3096 News Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigated Published: 09 September 2020; BMJ 370 doi:10.1136/bmj.m3525 See more Researchers hail use of anonymised GP data to drive diagnostics and treatment BMJ October 07, 2024, 387 q2201; DOI: https://doi.org/10.1136/bmj.q2201 Hurley Group sells eConsult digital platform to health technology company BMJ October 04, 2024, 387 q2184; DOI: https://doi.org/10.1136/bmj.q2184 Streeting vows to slash red tape in general practice BMJ October 04, 2024, 387 q2185; DOI: https://doi.org/10.1136/bmj.q2185 More GPs needed in deprived areas to reduce widening gap in provision, says RCGP chair BMJ October 04, 2024, 387 q2182; DOI: https://doi.org/10.1136/bmj.q2182 NHS England consults on rolling out obesity injection tirzepatide to meet demand BMJ October 04, 2024, 387 q2180; DOI: https://doi.org/10.1136/bmj.q2180 Cited by... Literature analysis of the efficacy of COVID-19 vaccinationsAbstract Fulltext PDF Structural violence and the biomedical innovation system: what responsibility do universities have in ensuring access to health technologies?Abstract Fulltext PDF Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigatedAbstract Fulltext PDF Covid-19: Where are we on immunity and vaccines?Abstract Fulltext PDF
